Table of Content - Peptide Therapeutics Market

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study:

This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide therapeutics market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Detailed Segmentation:

Global Peptide Therapeutics Market, By Product Type:
- Branded Peptide
- Generic Peptide
Global Peptide Therapeutics Market, By Application:
- Cancer
- Cardiovascular diseases
- Metabolic diseases
- Respiratory diseases
- Infectious diseases
- Others
Global Peptide Therapeutics Market, By Route of Administration:
- Oral Administration
- Parenteral Administration
- Others
Global Peptide Therapeutics Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Teva Pharmaceutical Industries Ltd.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novo Nordisk A/S
- OPKO Health, Inc.
- Lilly
- Hanmi Pharm.Co.
- Sanofi
- Circle Pharma
- Pfizer Inc.
- Novartis AG
- PeptiDream Inc.
- Amgen Inc.
- AstraZeneca
- Bachem Holding AG
- CordenPharma International
- Ipsen Pharma
- Merck KGaA
- PolyPeptide Group
- Bayer AG

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product Type
  - Market Snapshot, By Application
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Attractiveness Analysis
  - Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER’s Analysis
- Pricing Analysis (2021)
Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Peptide Therapeutics Market, By Product Type, 2017–2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Branded Peptide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Generic Peptide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Peptide Therapeutics Market, By Application, 2017–2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 - 2030
  - Segment Trends
- Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Cardiovascular Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Metabolic Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Respiratory Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Infectious Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Peptide Therapeutics Market, By Route of Administration, 2017–2030, (US$ Million)
- Oral Administration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Parenteral Administration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Peptide Therapeutics Market, By Region, 2017–2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017–2030, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017–2030, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017–2030, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017–2030, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- OPKO Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lilly
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hanmi Pharm.Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Circle Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PeptiDream Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bachem Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CordenPharma International
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ipsen Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PolyPeptide Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 35 market data tables and 32 figures on “Peptide Therapeutics Market”- Global forecast to 2030.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE